← Back to Search

Sustainability Strategies for Suicide Prevention (Sust-AIns Trial)

N/A

Waitlist Available

Led By Emily E. Haroz, PhD

Research Sponsored by Johns Hopkins Bloomberg School of Public Health

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Over the age of 18

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up up to 5 years

Awards & highlights

Sust-AIns Trial Summary

This trial will test different ways to help mental and behavioral health programs stay effective in tribal communities, using a mix of qualitative and quantitative methods.

Who is the study for?

This trial is for adults over 18 who speak English and are knowledgeable about implementing suicide prevention programs. Participants must be able to attend study meetings and assessments. Those under the influence, with active psychosis or mania, or any condition preventing informed consent cannot join.Check my eligibility

What is being tested?

The study tests sustainment strategy interventions designed to keep evidence-based mental and behavioral health programs running in tribal communities. It uses a combination of qualitative and quantitative research methods to evaluate these strategies.See study design

What are the potential side effects?

Since this trial focuses on sustainability strategies rather than medical treatments, traditional side effects associated with medications are not applicable here.

Sust-AIns Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am over 18 years old.

Sust-AIns Trial Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ up to 5 years

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~up to 5 years

This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 5 years for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Program Sustainability Assessment Tool

Sust-AIns Trial Design

1Treatment groups

Experimental Treatment

Group I: InterventionExperimental Treatment1 Intervention

Interrupted time series design

0 / 1Eligibility criteria met

Find a Location

Who is running the clinical trial?

Johns Hopkins Bloomberg School of Public HealthLead Sponsor

410 Previous Clinical Trials

2,116,902 Total Patients Enrolled

Emily E. Haroz, PhDPrincipal InvestigatorJohns Hopkins Bloomberg School of Public Health

Media Library

Intervention Clinical Trial Eligibility Overview. Trial Name: NCT03755206 — N/A

Program Sustainability Research Study Groups: Intervention

Program Sustainability Clinical Trial 2023: Intervention Highlights & Side Effects. Trial Name: NCT03755206 — N/A

Intervention 2023 Treatment Timeline for Medical Study. Trial Name: NCT03755206 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is this experiment presently enrolling participants?

"Based on what is posted on clinicaltrials.gov, this medical trial has stopped recruiting participants as of the last edit from October 4th 2022. While no longer open to enrollment, there are currently 168 other trials actively looking for qualified individuals."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Sust-AIns: Sustainment of Suicide Prevention Programs in American Indian Settings

2018. "Sust-AIns: Sustainment of Suicide Prevention Programs in American Indian Settings". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT03755206.